SCHEMBL397024

SCHEMBL397024

C=C(C)C(=O)OCCC[Si](OC)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
THRB P10828 1/20 0.41
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35807 0.92 TSHR (0.51) TSHRTHRBPOLBAPEX1HTT
SCHEMBL333002 0.90 TSHR (0.50) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5575866 0.90 TSHR (0.44) TSHRTHRBPOLBAPEX1HTT
SCHEMBL9444622 0.89 TSHR (0.46) TSHRTHRBPOLBAPEX1HTT
SCHEMBL26849839 0.89 TSHR (0.41) TSHRTHRBPOLBAPEX1HTT
SCHEMBL15276 0.89 TSHR (0.55) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5446210 0.89 TSHR (0.55) TSHRTHRBPOLBAPEX1HTT
SCHEMBL26363956 0.88 TSHR (0.43) TSHRTHRBPOLBAPEX1HTT
SCHEMBL11312974 0.88 TSHR (0.47) TSHRTHRBPOLBAPEX1HTT
SCHEMBL11312944 0.88 TSHR (0.47) TSHRTHRBPOLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10604658-B2 Organic silicon compound, surface treatment agent containing same, resin composition containing same, and gel or cured product of same DOW TORAY CO., LTD. (JP) 2020-03-31 US disclosed
US-9063408-B2 Methods and processes for modifying polymer material surface interactions OBDUCAT AB (SE) 2015-06-23 US disclosed
WO-2015022998-A1 NOVEL ORGANIC SILICON COMPOUND, SURFACE TREATMENT AGENT CONTAINING SAME, RESIN COMPOSITION CONTAINING SAME, AND GEL OR CURED PRODUCT OF SAME DOW CORNING TORAY CO., LTD. (JP) 2015-02-19 WO disclosed
US-8440738-B2 Silicone hydrogels and methods of manufacture CONTAMAC, LTD. (GB) 2013-05-14 US disclosed
US-8110697-B2 Method for the production of polymerizable silicones WACKER CHEMIE AG (DE) 2012-02-07 US disclosed
US-8101789-B2 Method for the production of polymerizable silicones WACKER CHEMIE AG (DE) 2012-01-24 US disclosed
EP-2125833-B1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES WACKER CHEMIE AG (DE) 2010-08-25 EP disclosed
EP-2125834-B1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES WACKER CHEMIE AG (DE) 2010-08-25 EP disclosed
US-20100041909-A1 METHOD FOR THE PRODUCTION OF POLYMERIZABLE SILICONES WACKER CHEMIE AG (DE) 2010-02-18 US disclosed
US-20100029972-A1 METHOD FOR THE PRODUCTION OF POLYMERIZABLE SILICONES WACKER CHEMIE AG (DE) 2010-02-04 US disclosed
EP-1510520-B1 Preparation of branched siloxane SHINETSU CHEMICAL CO (JP) 2006-07-26 EP disclosed
US-6943264-B2 Preparation of branched siloxane SHIN-ETSU CHEMICAL, CO., LTD. (JP) 2005-09-13 US disclosed
US-20050049427-A1 Preparation of branched siloxane SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-03-03 US disclosed
EP-1510520-A1 Preparation of branched siloxane Shin-Etsu Chemical Co., Ltd. (JP) 2005-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10604658-B2 Organic silicon compound, surface treatment agent containing same, resin composition containing same, and gel or cured product of same ASH2L, RPS7, MRPS27 TSHR 3888/4885THRB 4137/4885POLB 2037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.